| scholarly article | Q13442814 |
| P50 | author | David A Bennett | Q66739430 |
| P2093 | author name string | Jing Tian | |
| Robert G Hamilton | |||
| Qian-Li Xue | |||
| Jeremy D Walston | |||
| Alka Jain | |||
| Neal S Fedarko | |||
| Peter M Abadir | |||
| Laura J Powell | |||
| Thomas Finucane | |||
| P2860 | cites work | The frail renin-angiotensin system | Q37150747 |
| Inflammation and hypertension: the interplay of interleukin-6, dietary sodium, and the renin-angiotensin system in humans | Q37252413 | ||
| Role of the renin-angiotensin system in prostate cancer | Q37281855 | ||
| Inflammatory signaling and cellular senescence | Q37320836 | ||
| Endothelin-1, oxidative stress, and endogenous angiotensin II: mechanisms of angiotensin II type I receptor autoantibody-enhanced renal and blood pressure response during pregnancy | Q37353537 | ||
| Pre-eclampsia rates in the United States, 1980-2010: age-period-cohort analysis | Q37502951 | ||
| Fibrosis, a common pathway to organ failure: angiotensin II and tissue repair | Q41605140 | ||
| Agonistic autoantibodies directed against the angiotensin II AT1 receptor in patients with preeclampsia | Q44413491 | ||
| Angiotensin II type 1-receptor activating antibodies in renal-allograft rejection | Q45259438 | ||
| Inflammatory markers and physical performance in older persons: the InCHIANTI study | Q47925065 | ||
| Inflammation and frailty in older women. | Q53549699 | ||
| Identification of macrophage receptors for angiotensin: a potential role in antigen uptake for T lymphocyte responses? | Q53910828 | ||
| Lean mass, muscle strength and gene expression in community dwelling older men: findings from the Hertfordshire Sarcopenia Study (HSS). | Q54197697 | ||
| Autoantibodies against the angiotensin receptor (AT1) in patients with hypertension | Q74126541 | ||
| Specific removal of beta1-adrenergic autoantibodies from patients with idiopathic dilated cardiomyopathy | Q78587830 | ||
| Direct detection of carcinoembryonic antigen autoantibodies in clinical human serum samples using a surface plasmon resonance sensor | Q83212723 | ||
| Disruption of the Ang II type 1 receptor promotes longevity in mice | Q24647615 | ||
| Frailty in older adults: evidence for a phenotype | Q28205094 | ||
| The human anti-thyroid peroxidase autoantibody repertoire in Graves' and Hashimoto's autoimmune thyroid diseases | Q28205624 | ||
| Frailty and activation of the inflammation and coagulation systems with and without clinical comorbidities: results from the Cardiovascular Health Study | Q28213764 | ||
| Subcellular characteristics of functional intracellular renin-angiotensin systems. | Q30417227 | ||
| Angiotensin II Type-2 receptors modulate inflammation through signal transducer and activator of transcription proteins 3 phosphorylation and TNFα production. | Q30426697 | ||
| Irbesartan, an angiotensin type 1 receptor inhibitor, regulates markers of inflammation in patients with premature atherosclerosis | Q32054951 | ||
| Frailty and the older man. | Q33741415 | ||
| Patients with preeclampsia develop agonistic autoantibodies against the angiotensin AT1 receptor | Q33848380 | ||
| Age-associated increased interleukin-6 gene expression, late-life diseases, and frailty | Q33896033 | ||
| Antihypertensive medications and serious fall injuries in a nationally representative sample of older adults | Q34061043 | ||
| Keeping pace with ACE: are ACE inhibitors and angiotensin II type 1 receptor antagonists potential doping agents? | Q34886182 | ||
| Inflammation and angiotensin II. | Q35099157 | ||
| Losartan restores skeletal muscle remodeling and protects against disuse atrophy in sarcopenia | Q35118372 | ||
| Novel roles of nuclear angiotensin receptors and signaling mechanisms | Q35850244 | ||
| Myostatin as a mediator of sarcopenia versus homeostatic regulator of muscle mass: insights using a new mass spectrometry-based assay | Q35853649 | ||
| Activating auto-antibodies against the AT1 receptor in preeclampsia | Q36010629 | ||
| Overview and findings from the religious orders study | Q36130996 | ||
| Overview and findings from the rush Memory and Aging Project | Q36226167 | ||
| The molecular inflammatory process in aging | Q36469303 | ||
| Agonist autoantibodies against the angiotensin AT1 receptor in renal and hypertensive disorders | Q36794943 | ||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | autoantibody | Q785022 |
| biomarker | Q864574 | ||
| P304 | page(s) | 449-459 | |
| P577 | publication date | 2016-11-30 | |
| P1433 | published in | Circulation | Q578091 |
| P1476 | title | Discovery and Validation of Agonistic Angiotensin Receptor Autoantibodies as Biomarkers of Adverse Outcomes. | |
| P478 | volume | 135 |
| Q92594858 | Angiotensin receptor autoantibodies as exposures that modify disease progression: Cross sectional, longitudinal and in vitro studies of prostate cancer |
| Q107324240 | Autoantibodies against ACE2 and angiotensin type-1 receptors increase severity of COVID-19 |
| Q90599535 | Autoantibodies against AT1 Receptor Contribute to Vascular Aging and Endothelial Cell Senescence |
| Q50077615 | Autoantibodies against angiotensin and adrenergic receptors: more than a biomarker? |
| Q47581048 | Long-term presence of angiotensin II type 1 receptor autoantibody reduces aldosterone production by triggering Ca(2+) overload in H295R cells |
| Q88978899 | Religious Orders Study and Rush Memory and Aging Project |
Search more.